Metabolic activity in immune cells influences the fate of developing T cells, including a protein complex that plays a decisive role.
Surveys from the Childhood Cancer Survivor Study found that a surprisingly high number of survivors showed a lack of concern for their future well-being.
Researchers have applied a new way to trigger medulloblastoma in neural cells that will lead to the ability to test a promising class of anti-tumor drugs.
Check out a new algorithm that is available at no cost to help researchers get the most out of single-cell RNA sequencing technology.
St. Jude partners with nation’s top cancer centers to endorse goal of eliminating HPV-related cancers in the United States
Joint statement empowers parents, young adults and physicians to act to increase vaccination rates and screenings to eliminate HPV-related cancers
Study found ethanol-lock therapy failed to prevent new or recurring infections in cancer patients with central venous catheters and led to more complications.
St. Jude experts share pediatric oncology and survivorship research at the annual meeting of the American Society of Clinical Oncology.
Read about the algorithm that helped researchers uncover hidden drivers of immune regulation and production of anti-tumor T cells.
Hospital invests more than $100 million to improve childhood cancer survival rates worldwide.
For a subset of the youngest patients with the brain tumor medulloblastoma, less aggressive therapy was associated with better long-term survival.
Explore more research news
More Research News
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Courageous patients. Resolute doctors. Caring staff. Inventive scientists. Their voices come alive in Promise magazine.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Browse all scientific publications by St. Jude investigators.